𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Classical Hodgkin lymphoma is associated with frequent gains of 17q

✍ Scribed by Daniel T.Y. Chui; David Hammond; Margaret Baird; Lesley Shield; Robert Jackson; Ruth F. Jarrett


Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
297 KB
Volume
38
Category
Article
ISSN
1045-2257

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The etiology of Hodgkin lymphoma (HL) is poorly understood, and studies of the genetics of this disease have been hampered by the scarcity of the Hodgkin and Reed–Sternberg (HRS) cells within tumors. To determine whether recurrent genomic imbalances are a feature of HL, CD30‐positive HRS cells were laser‐microdissected from 20 classical Hodgkin lymphomas (cHLs) and four HL‐derived cells lines and subjected to analyses by comparative genomic hybridization. In primary tumors, the most frequently involved chromosomal gains were 17q (70%), 2p (40%), 12q (40%), 17p (40%), 22q (35%), 9p (30%), 14q (30%), and 16p (30%), with minimal overlapping regions at 17q21, 2p23–13, 12q24, 17p13, 22q13, 9p24–23, 14q32, 16p13.3, and 16p11.2. The most frequent losses involved 13q (35%), 6q (30%), 11q (25%), and 4q (25%), with corresponding minimal overlapping regions at 13q21, 6q22, 11q22, and 4q32. Statistical analysis revealed significantly more gains of 2p and 14q in the older adult cases; loss of 13q was associated with a poor outcome. The results suggest that there is a set of recurrent chromosomal abnormalities associated with cHL and provide further evidence that cHL is genetically distinct from nodular lymphocyte predominance Hodgkin lymphoma (NLPHL). Abnormalities of 17q are infrequent in other lymphomas or NLPHL; this finding, coupled with current knowledge of gene expression in cHL, suggests that genes present on 17q may play an important role in the pathogenesis of cHL. © 2003 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Frequent silencing of fragile histidine
✍ Azhar Hussain; Marina I. Gutiérrez; Georgina Timson; Abdul K. Siraj; Clara Deamb 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 230 KB

## Abstract The fragile histidine triad (__FHIT__) gene, a potential tumor‐suppressor gene, is frequently inactivated in multiple human cancers. However, the __FHIT__ gene remains largely unexplored in Burkitt's lymphoma (BL). Hence, we assessed whether loss of __FHIT__ expression occurs in BL, and

Chromosome 1q loss of heterozygosity fre
✍ Ying-Mai Yang; Tong-Hua Liu; Yuan-Jia Chen; Wei-Jun Jiang; Jia-Ming Qian; Xin Lu 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 266 KB 👁 1 views

## Abstract The pathogenesis of sporadic insulinomas is not clear, and there are no reliable genetic determinants that are useful to distinguish malignant and benign forms of this tumor. It was reported that 1q LOH might contribute to pathogenesis in gastrinomas and was correlated with tumor progre

Primary myelofibrosis is the most freque
✍ Rafael Santana-Davila; Ayalew Tefferi; Shernan G. Holtan; Rhett P. Ketterling; G 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 879 KB

Among 23 cases of myeloproliferative neoplasms (MPNs) with an associated del(5q) seen at our institution, 14 (61%) fulfilled diagnostic criteria for primary myelofibrosis (PMF). Other diagnoses included polycythemia vera (PV; n = 2), essential thrombocythemia (ET; n = 1), post-ET myelofibrosis (n =